0.1070NOK-3.43%Mkt Cap: 273.43M NOKP/E: —Last update: 2026-06-01
SoftOx Solutions AS, together with its subsidiaries, operates as a clinical-stage pharmaceutical company that develops antimicrobials products for infection prevention and treatment in Norway. The company develops SoftOx…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap273.43M NOK
Enterprise Value245.06M NOK
Revenue (TTM)15.58M NOK
Gross Profit15.58M NOK
Net Income (TTM)-10.81M NOK
Revenue/Share0.0070 NOK
Last Price0.1070 NOK
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees—
CountryNO
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-29.96
EV/Revenue15.73
P/S18.17
P/B11.08
EPS (TTM)0.00
EPS (Forward)—
52W Range
0.049050% of range0.1658
52W High0.1658 NOK
52W Low0.0490 NOK
Profitability
Gross Margin100.00%
Oper. Margin-107.09%
EBITDA Margin-52.49%
Profit Margin-69.39%
ROE-47.11%
ROA-31.87%
Growth
Revenue Growth123.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF-18.87M NOK
CapEx (TTM)—
FCF Margin-121.16%
FCF Yield-6.91%
Net Debt-19.79M NOK
Net Debt/EBITDA2.42
Balance Sheet
Debt/Equity0.00
Current Ratio1.80
Quick Ratio1.80
Book Value/Sh0.0100 NOK
Cash/Share0.0080 NOK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 NOK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split50:1
Split DateJul 2, 2018
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.2.56B
Float1.04B
Insiders55.76%
Institutions3.13%
Technical
SMA 500.1078 (-0.7%)
SMA 2000.0837 (+27.8%)
Beta0.98
S&P 52W Chg27.70%
Avg Vol (30d)36.74M
Avg Vol (10d)35.96M
Technical Indicators
RSI (14)48.3
MACD0.0025
MACD Signal0.0041
MACD Hist.-0.0016
BB Upper0.1309 NOK
BB Middle0.1147 NOK
BB Lower0.0985 NOK
BB Width28.24%
ATR (14)0.0133 NOK
Vol Ratio (20d)0.59x